Track: Covid and Its Impact on Cancer

Covid and Its Impact on Cancer

Covid and Its Impact on Cancer session will delve into the multifaceted impact of the COVID-19 pandemic on cancer research, treatment, and patient care. The pandemic disrupted essential cancer screenings, diagnoses, and treatments, resulting in delayed care and potential increases in late-stage cancer diagnoses. We will discuss how healthcare systems adapted to these unprecedented challenges and the long-term effects on patient outcomes. Key topics will include the impact of COVID-19 on cancer-related mortality and morbidity, adjustments in clinical trials, and the integration of telemedicine in oncology practice. 

Delays in Diagnosis:
Examine the factors contributing to delays in cancer diagnosis and their impact on patient outcomes. Delays in Diagnosis sub-session highlights challenges such as healthcare system disruptions, patient awareness, and access to medical services, while exploring strategies to enhance early detection and timely treatment.

Treatment Interruptions:
Discuss the causes and consequences of treatment interruptions in cancer care, including healthcare disruptions, patient factors, and resource limitations. This sub-session will explore the impact on treatment outcomes, strategies for continuity of care, and best practices for minimizing disruptions.

Increased Risk for Cancer Patients:
Explore the heightened risks cancer patients face, including complications from comorbidities, treatment side effects, and susceptibility to infections. Increased Risk for Cancer Patients sub-session will discuss strategies to manage these risks, improve patient safety, and enhance overall outcomes in cancer care.

Impact on Mental Health:
Explore the profound effects of cancer diagnosis and treatment on mental health, including anxiety, depression, and stress. This sub-session will address coping strategies, the importance of psychological support, and approaches to integrate mental health care into oncology practice.

Telemedicine Adoption:
Explore the accelerated adoption of telemedicine in oncology due to the COVID-19 pandemic and its lasting implications. Telemedicine Adoption sub-session covers benefits, challenges, and best practices for virtual consultations, enhancing patient access, and maintaining continuity of care in cancer treatment.